Kriya Therapeutics Inc. and the Universitat Autònoma de Barcelona have published preclinical data for KRIYA-497, a one-time intramuscular gene therapy being developed for the treatment of metabolic ...

Gene therapy biotech Kriya Therapeutics has acquired Tramontane Therapeutics, a startup focused on metabolic diseases. Tramontane brings a gene therapy that’s a potential one-time treatment for ...

and RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Kriya Therapeutics, Inc., ("Kriya"), a biopharmaceutical company developing gene therapies to address common diseases affecting ...

PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Kriya Therapeutics, Inc., ("Kriya"), a biopharmaceutical company developing gene therapies to address common ...